IRadimed Reports Q4 Earnings

Medical device maker posts $6.4 million in net income for the quarter.

Published on Feb. 10, 2026

Got story updates? Submit your updates here. ›

IRadimed Corp., a maker of IV devices for use in MRI machines, reported net income of $6.4 million in the fourth quarter. The Orlando, Florida-based company said earnings were 54 cents per share, adjusted for stock option expense. IRadimed posted revenue of $22.7 million in the period.

Why it matters

IRadimed's quarterly and annual financial results provide insight into the performance of the medical device industry, particularly companies focused on products compatible with MRI technology. The company's guidance for the current quarter also gives an indication of expected near-term trends.

The details

For the full year, IRadimed reported a profit of $22.5 million, or $1.75 per share, on revenue of $83.8 million. For the current quarter ending in March, the company expects earnings per share to range from 44 to 48 cents, with revenue between $21 million and $22 million.

  • IRadimed reported its Q4 2025 earnings on February 10, 2026.
  • The company provided guidance for Q1 2026, the quarter ending in March 2026.

The players

IRadimed Corp.

A medical device company that makes IV devices compatible for use in MRI machines.

Got photos? Submit your photos here. ›

What’s next

Investors will be watching to see if IRadimed can meet its Q1 2026 guidance when the company reports those results in the coming months.

The takeaway

IRadimed's solid Q4 2025 performance and near-term outlook suggest continued strength in the medical device industry, particularly for companies focused on products that can be used alongside advanced imaging technologies like MRI.